Tourandokht Baluchnejadmojarad Selected Research

S-allylcysteine (allyl cysteine)

5/2020	S-allyl cysteine, an active ingredient of garlic, attenuates acute liver dysfunction induced by lipopolysaccharide/ d-galactosamine in mouse: Underlying mechanisms.
4/2019	S-allyl cysteine protects against lipopolysaccharide-induced acute kidney injury in the C57BL/6 mouse strain: Involvement of oxidative stress and inflammation.
1/2018	S-allyl cysteine improves clinical and neuropathological features of experimental autoimmune encephalomyelitis in C57BL/6 mice.
1/2017	S-allyl cysteine ameliorates cognitive deficits in streptozotocin-diabetic rats via suppression of oxidative stress, inflammation, and acetylcholinesterase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tourandokht Baluchnejadmojarad Research Topics

Disease

27	Inflammation (Inflammations) 10/2022 - 05/2016
18	Neuroinflammatory Diseases 08/2022 - 12/2016
13	Gliosis 01/2021 - 11/2013
12	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2015
9	Cognitive Dysfunction 08/2022 - 01/2006
9	Memory Disorders (Memory Loss) 01/2019 - 10/2011
8	Temporal Lobe Epilepsy 10/2022 - 01/2013
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 07/2010
7	Parkinson Disease (Parkinson's Disease) 01/2020 - 08/2010
5	Status Epilepticus (Complex Partial Status Epilepticus) 10/2022 - 01/2013
5	Seizures (Absence Seizure) 06/2022 - 01/2013
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2021 - 01/2018
4	Demyelinating Diseases (Demyelinating Disease) 10/2021 - 01/2018
4	Epilepsy (Aura) 01/2021 - 11/2013
4	Body Weight (Weight, Body) 12/2019 - 10/2018
4	Hyperalgesia 02/2017 - 01/2010
3	Nervous System Diseases (Neurological Disorders) 10/2022 - 10/2015
3	Acute Kidney Injury (Acute Renal Failure) 09/2022 - 10/2018
3	Acute Liver Failure (Fulminant Hepatic Failure) 06/2022 - 09/2020
3	Multiple Sclerosis 10/2021 - 01/2021
2	Sepsis (Septicemia) 09/2022 - 10/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 11/2020
2	Pain (Aches) 12/2019 - 02/2017
2	Diabetes Mellitus 12/2015 - 09/2011
2	Metabolic Diseases (Metabolic Disease) 02/2010 - 08/2009
2	Diabetes Complications 07/2008 - 10/2007
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2022
1	Liver Failure 06/2022
1	Dementia (Dementias) 01/2022

Drug/Important Bio-Agent (IBA)

11	AntioxidantsIBA 09/2022 - 08/2010
11	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2006
10	LipopolysaccharidesIBA 09/2022 - 01/2018
9	NF-kappa B (NF-kB)IBA 10/2022 - 05/2016
8	Kainic Acid (Kainate)IBA 10/2022 - 01/2013
7	Neuroprotective AgentsIBA 10/2022 - 08/2010
7	Amyloid (Amyloid Fibrils)IBA 01/2022 - 04/2016
7	Oxidopamine (6 Hydroxydopamine)IBA 12/2017 - 07/2010
6	Malondialdehyde (Propanedial)IBA 10/2022 - 08/2010
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 12/2016
6	DiosgeninIBA 10/2021 - 12/2015
5	Caspase 1 (ICE Protease)IBA 10/2022 - 05/2020
5	Anticonvulsants (Antiepileptic Drugs)IBA 10/2022 - 11/2013
5	Glial Fibrillary Acidic ProteinIBA 10/2022 - 05/2016
4	Toll-Like Receptor 4IBA 10/2022 - 01/2017
4	Sirtuin 1IBA 06/2022 - 08/2018
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2019
4	S-allylcysteine (allyl cysteine)IBA 05/2020 - 01/2017
4	Formaldehyde (Formol)FDA Link 12/2019 - 01/2010
4	pelargonidinIBA 10/2016 - 01/2010
4	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2012 - 08/2009
4	TeaIBA 01/2012 - 08/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022 - 04/2017
3	Heme Oxygenase-1IBA 10/2022 - 12/2016
3	sinomenineIBA 08/2022 - 10/2020
3	Cholinergic Agents (Cholinergics)IBA 01/2021 - 10/2016
3	Ellagic AcidIBA 01/2021 - 01/2017
3	CytokinesIBA 01/2021 - 09/2019
3	Cholinesterases (Cholinesterase)IBA 12/2019 - 10/2016
3	BerberineIBA 01/2019 - 04/2014
3	naringeninIBA 05/2018 - 01/2006
3	AcetylcholinesteraseIBA 06/2017 - 01/2017
3	CatalaseIBA 05/2017 - 05/2016
2	Therapeutic UsesIBA 09/2022 - 10/2021
2	Acetylcarnitine (Alcar)IBA 06/2022 - 05/2017
2	3-methylquercetinIBA 06/2022 - 12/2019
2	Acetaminophen (Paracetamol)FDA LinkGeneric 06/2022 - 06/2022
2	FlavonoidsIBA 01/2022 - 10/2018
2	SilverIBA 10/2021 - 01/2018
2	Luxol Fast Blue MBS (Luxol fast blue)IBA 10/2021 - 01/2018
2	InflammasomesIBA 02/2021 - 01/2021
2	Sirtuin 3IBA 01/2021 - 10/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 10/2011
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2017
2	LinagliptinIBA 01/2021 - 12/2020
2	Peptides (Polypeptides)IBA 01/2021 - 01/2021
2	GalactosamineIBA 01/2021 - 05/2020
2	EnzymesIBA 05/2020 - 08/2010
2	Biomarkers (Surrogate Marker)IBA 05/2020 - 10/2018
2	Superoxide DismutaseIBA 05/2020 - 08/2010
2	troxerutinIBA 10/2019 - 04/2017
2	Glucose (Dextrose)FDA LinkGeneric 05/2019 - 10/2018
2	Testosterone (Sustanon)FDA Link 05/2019 - 10/2018
2	AlkaloidsIBA 01/2019 - 01/2019
2	trigonellineIBA 01/2019 - 08/2018
2	sesaminIBA 10/2018 - 04/2017
2	hesperetinIBA 10/2018 - 05/2016
2	IsoflavonesIBA 01/2018 - 07/2008
2	GenisteinIBA 01/2018 - 07/2008
2	Amyloid beta-PeptidesIBA 06/2017 - 10/2015
2	cyanidin-3-O-beta-glucopyranosideIBA 08/2012 - 09/2011
2	Hypoglycemic Agents (Hypoglycemics)IBA 08/2012 - 09/2011
2	SilymarinIBA 08/2010 - 08/2010
1	paeonolIBA 10/2022
1	Transcription Factors (Transcription Factor)IBA 09/2022
1	LycopeneIBA 09/2022
1	trimethyltinIBA 08/2022
1	sinapinic acidIBA 06/2022
1	3-nitrotyrosineIBA 01/2022

Therapy/Procedure

5	Therapeutics 01/2021 - 07/2010
1	Critical Care (Surgical Intensive Care) 09/2022